SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Maintain Significant Stake in Nuvation Bio Inc.
Beneficial Ownership Report
FMR LLC and its affiliates, along with Abigail P. Johnson, reported a continued beneficial ownership of 13.5% of Nuvation Bio Inc.'s Class A Common Stock as of December 31, 2024.
Summary
- FMR LLC and Abigail P. Johnson collectively beneficially own 45,285,572 shares of Nuvation Bio Inc.'s Class A Common Stock.
- This represents 13.5% of the total outstanding Class A Common Stock.
- The filing is an Amendment No. 6 to a Schedule 13G, indicating an update to a previously reported beneficial ownership.
- FMR LLC holds sole voting power over 45,281,145 shares and sole dispositive power over 45,285,572 shares.
- Abigail P. Johnson holds sole dispositive power over 45,285,572 shares.
- Fidelity Growth Company Commingled Pool, a subsidiary of FMR LLC, is known to have an interest in 16,999,867 shares, representing 5.1% of the Class A Common Stock.
- The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Nuvation Bio Inc.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently lead to a positive or negative sentiment regarding the issuer's performance or outlook.
Positives
- Continued significant institutional investment by FMR LLC and its affiliates, indicating confidence in Nuvation Bio Inc.
Negatives
- No negative information regarding Nuvation Bio Inc's operations or financial health is disclosed in this ownership report.
Risks
- No specific risks related to Nuvation Bio Inc's operations or financial health are disclosed in this ownership report. The document focuses on the reporting entity's ownership.
Future Outlook
This Schedule 13G filing does not contain any forward-looking statements or guidance regarding Nuvation Bio Inc's future performance or strategic direction.
Management Comments
- "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities."
Industry Context
This filing is a routine disclosure of beneficial ownership by a large institutional investor, FMR LLC (Fidelity), in a publicly traded company, Nuvation Bio Inc. It reflects the ongoing investment activities of major asset managers within the broader market, without providing specific industry-related insights or trends for Nuvation Bio Inc's sector.
Comparison to Industry Standards
- This document is a standard beneficial ownership disclosure (Schedule 13G) and does not contain financial or operational results for Nuvation Bio Inc that would allow for a comparison to industry benchmarks or specific comparable companies/projects. It solely reports the ownership stake of FMR LLC and Abigail P. Johnson.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Governance Structure Disclosure | Members of the Johnson family, including Abigail P. Johnson, are the predominant owners of Series B voting common shares of FMR LLC (49% voting power) and have a shareholders' voting agreement to vote in accordance with the majority, potentially forming a controlling group for FMR LLC. | N/A | This describes the internal control structure of the reporting entity (FMR LLC) and does not directly impact Nuvation Bio Inc's corporate governance. |
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holder's stake, which can influence market perception and liquidity.
Next Steps
- The document does not mention any specific future actions, events, or milestones for Nuvation Bio Inc or the reporting persons beyond the routine filing requirements.
Key Dates
| Date | Description |
|---|---|
| 01/03/2023 | Effective date of Power of Attorney for FMR LLC. |
| 01/26/2023 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 12/31/2024 | Date of event which requires filing of this statement (reporting period end date). |
| 02/11/2025 | Date of filing and signature for the Schedule 13G Amendment No. 6. |
Keywords
NUVATION BIO INC, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Class A Common Stock, Institutional Investor, Fidelity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.